SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-23-180386
Filing Date
2023-06-30
Accepted
2023-06-30 16:06:39
Documents
10
Effectiveness Date
2023-06-30

Document Format Files

Seq Description Document Type Size
1 S-8 d487243ds8.htm S-8 64642
2 EX-5.1 d487243dex51.htm EX-5.1 8767
3 EX-23.2 d487243dex232.htm EX-23.2 1685
4 EX-99.1 d487243dex991.htm EX-99.1 100211
5 EX-99.2 d487243dex992.htm EX-99.2 33646
6 EX-99.3 d487243dex993.htm EX-99.3 12503
7 EX-99.4 d487243dex994.htm EX-99.4 13280
8 EX-FILING FEES d487243dexfilingfees.htm EX-FILING FEES 33056
9 GRAPHIC g487243g0629002244949.jpg GRAPHIC 2527
10 GRAPHIC g487243g0629004321254.jpg GRAPHIC 2534
  Complete submission text file 0001193125-23-180386.txt   276297
Mailing Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121
Business Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121 8582514400
HERON THERAPEUTICS, INC. /DE/ (Filer) CIK: 0000818033 (see all company filings)

IRS No.: 942875566 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-273059 | Film No.: 231061744
SIC: 2834 Pharmaceutical Preparations